Subscribe to Search results

In a letter to Dr Arblaster, a patient's father requested that his son be withdrawn from any further use of the treatment of the first prophylactic trial due to the extra pain and distress it had caused.

Published on:

Dr Aronstam told the Treloar's governing body that "although very few of the haemophiliac boys carrying the AIDS antibodies would develop AIDS, this meant that at least one would do so at some stage".

Published on:

Timetable for public hearings 4 - 7 June 2019

Published on:

Public hearings factsheet

Published on:

Timetable for public hearings 11-14 June and 18-21 June 2019 (Leeds)

Published on:

Public hearings factsheet

Published on:

Inquiry publishes timetable and opens registration for May hearings

Published on:

Inquiry publishes financial report

Published on:

Compensation Framework Study

Published on:

Inquiry publishes timetable and opens registration for hearings in June

Published on:

Inquiry publishes timetable and opens registration for Treloar’s hearings

Published on:

Government announcement on expenses for legal representation

Published on:

Letter of Instruction to Public Health and Administration Group

Published on:

Inquiry Chair sets out plans for hearings in 2022

Published on:

Further instruction letter to Hepatitis expert group published

Published on:

Compensation Framework Study online

Published on:

Further information on submissions

Published on:

Public hearings factsheet - Cardiff (23-26 July)

Published on:

Timetable for public hearings 23-26 July 2019 (Cardiff)

Published on:

Update on January hearings 

Published on: